Game Changers for cervical cancer prevention in Uganda
Official title: A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda
Funded at Rand Corporation · NIH-11535796 · Data updated 2026-11-12
A community-based program helps women who have been screened share knowledge to encourage more women to get screened for cervical cancer in Uganda.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project start | August 8, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $16,795 |
| NIH project number | 3R01CA282284-04S2 |
| Project ID | NIH-11535796 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women in Uganda who have not yet been screened for cervical cancer or who are part of social networks that influence screening decisions, and who can participate in group sessions.
✕Less likely to help
Women who are not open to group-based education or who cannot participate in sessions may receive little or no benefit.
What this research studies
This project tests a peer-led, 7-session program designed to spread accurate cervical cancer information and reduce stigma so more Ugandan women undergo VIA screening. It uses a hybrid type 1 design to measure both how well the program works and how it can be put into practice in real settings. If successful, the approach could be adapted to other low-resource areas to boost early detection and reduce advanced cancers.
Why it matters
Potential benefit: If successful, this program could increase cervical cancer screening uptake and reduce late-stage cancers among Ugandan women.
How similar studies have gone: Previous pilot work showed increased screening among social network members when using peer-led approaches.
Where this research is happening
-
Rand Corporation
Santa Monica, United States Active
Researchers
- Principal investigator: Wagner, Glenn John — Rand Corporation
- Study coordinator: Wagner, Glenn John
Related research
Other NIH-funded projects on the same topics.
-
Community and digital tools to reduce HPV and cervical cancer burden
A nurse or health team will test a community-based, digital strategy to help girls and young women, especially in rural areas, get HPV vaccination and cervical cancer prevention services.
-
Community and digital tools to reduce HPV and cervical cancer in women with HIV
A community- and digital-technology program aims to help girls and young women, including those with HIV, get more HPV vaccination and cervical cancer prevention services.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
Hybrid approach to boost cervical cancer screening in Uganda
A tested, community-driven program helps Ugandan women encourage their peers to get free VIA cervical cancer screening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.